# Posidonia oceanica (L.) Delile as a Marine Anti-Inflammatory Modulator of Keratinocyte Inflammatory Responses Relevant to Psoriasis

**Authors:** Marzia Vasarri, Donatella Degl’Innocenti, Matteo Lulli, Nicola Schiavone, Alice Verdelli, Marzia Caproni, Emiliano Antiga, Emanuela Barletta

PMC · DOI: 10.3390/md24020085 · Marine Drugs · 2026-02-19

## TL;DR

This study shows that an extract from Posidonia oceanica reduces inflammation in skin cells linked to psoriasis, suggesting it could be a useful marine-derived treatment.

## Contribution

The study identifies the anti-inflammatory and antioxidant mechanisms of Posidonia oceanica extract in human keratinocytes, supporting its potential as a marine-derived therapeutic for psoriasis.

## Key findings

- POE significantly reduced oxidative stress and pro-inflammatory cytokine production in LPS-stimulated keratinocytes.
- POE restored cell proliferation and normalized inflammatory markers without affecting cell viability.
- POE induced a mild pro-apoptotic response, potentially counteracting apoptosis resistance in psoriatic keratinocytes.

## Abstract

Skin inflammation is characterized by oxidative stress, excessive keratinocyte activation, and the overproduction of pro-inflammatory cytokines. In a previous study, we demonstrated that the hydroalcoholic extract from Posidonia oceanica leaves (POE) mitigates psoriasis-like skin inflammation in a mouse model. In the present study, we investigated the cellular mechanisms underlying these effects in human HaCaT keratinocytes. Non-cytotoxic lipopolysaccharide (LPS) stimulation reproduced key inflammatory features, including impaired cell proliferation, increased production of ROS and NO, and the upregulation of IL-1β, IL-6, TNF-α and CXCL8/IL-8. Co-treatment with POE significantly attenuated these alterations by restoring cell proliferation, suppressing oxidative stress, particularly NOS2/NO, and normalizing both cytokine expression and release. POE alone did not affect cell viability or inflammatory markers, confirming its favorable safety profile. However, POE alone induced a mild pro-apoptotic response, which may contribute to overcoming the apoptosis resistance typically observed in psoriatic keratinocytes. Overall, these findings demonstrate that POE exerts antioxidant and anti-inflammatory effects in activated keratinocytes and support its potential as a marine-derived candidate for complementary strategies in the management of psoriasis-associated inflammatory skin disorders.

## Linked entities

- **Proteins:** NOS2 (nitric oxide synthase 2), IL1B (interleukin 1 beta), IL6 (interleukin 6), TNF (tumor necrosis factor)
- **Chemicals:** NO (PubChem CID 24822)
- **Diseases:** psoriasis (MONDO:0005083)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** LCN2 (lipocalin 2) [NCBI Gene 3934] {aka 24p3, MSFI, NGAL, p25}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IL22 (interleukin 22) [NCBI Gene 50616] {aka IL-21, IL-22, IL-D110, IL-TIF, ILTIF, TIFIL-23}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, HSPA4 (heat shock protein family A (Hsp70) member 4) [NCBI Gene 3308] {aka APG-2, HEL-S-5a, HS24/P52, HSPH2, RY, hsp70}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, TICAM1 (TIR domain containing adaptor molecule 1) [NCBI Gene 148022] {aka IIAE6, MyD88-3, PRVTIRB, TICAM-1, TRIF}, LBP (lipopolysaccharide binding protein) [NCBI Gene 3929] {aka BPIFD2}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, GDF5 (growth differentiation factor 5) [NCBI Gene 8200] {aka BDA1C, BMP-14, BMP14, CDMP1, DUPANS, LAP-4}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, CD14 (CD14 molecule) [NCBI Gene 929], CAT (catalase) [NCBI Gene 847], FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, TNFRSF8 (TNF receptor superfamily member 8) [NCBI Gene 943] {aka CD30, D1S166E, Ki-1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il23a (interleukin 23, alpha subunit p19) [NCBI Gene 83430] {aka IL-23, p19}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, LY96 (lymphocyte antigen 96) [NCBI Gene 23643] {aka ESOP-1, MD-2, MD2, ly-96}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, HSP90AA1 (heat shock protein 90 alpha family class A member 1) [NCBI Gene 3320] {aka EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, Il17f (interleukin 17F) [NCBI Gene 257630] {aka IL-17F}, Lcn2 (lipocalin 2) [NCBI Gene 16819] {aka 24p3, NRL, Sip24}
- **Diseases:** skin neoplasia (MESH:D009369), injury to (MESH:D014947), Inflammatory (MESH:D007249), inflammatory skin conditions (MESH:D012871), hidradenitis suppurativa (MESH:D017497), Psoriasis (MESH:D011565), Psoriatic (MESH:D015535), immune (MESH:D007154), dermatological disorders (MESH:D000168), cytotoxic (MESH:D064420), tumorigenic (MESH:D002471), atopic dermatitis (MESH:D003876), necrosis (MESH:D009336), chronic (MESH:D002908), inflammatory skin disorders (MESH:D012868), contact dermatitis (MESH:D003877)
- **Chemicals:** NO2- (MESH:D009585), 2',7'-dichlorodihydrofluorescein diacetate (MESH:C110400), sodium nitrite (MESH:D012977), DPPH (MESH:C004931), 7-AAD (MESH:C025942), oxygen (MESH:D010100), formazan (MESH:D005562), gallic acid (MESH:D005707), ascorbic acid (MESH:D001205), calcium chloride (MESH:D002122), NO (MESH:D009569), tetrazolium salt (MESH:D013778), water (MESH:D014867), (-)-epicatechin (MESH:D002392), DCF-DA (MESH:C029569), Griess reagent (MESH:C095000), ferulic acid (MESH:C004999), Nitrite (MESH:D009573), MTT (MESH:C070243), NO (MESH:D009614), phenol red (MESH:D010637), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), NaHCO3 (MESH:D017693), H2O2 (MESH:D006861), 1H (-), imiquimod (MESH:D000077271), ROS (MESH:D017382), D-glucose (MESH:D005947), chlorogenic acid (MESH:D002726), DMSO (MESH:D004121), CO2 (MESH:D002245), L-glutamine (MESH:D005973), polyphenol (MESH:D059808), LPS (MESH:D008070)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Posidonia oceanica (species) [taxon 55489]
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941391/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941391/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941391/full.md

---
Source: https://tomesphere.com/paper/PMC12941391